Literature DB >> 33499907

The National Immunization Technical Advisory Group in Israel.

Chen Stein-Zamir1,2,3, Shmuel Rishpon4,5,6.   

Abstract

National Immunization Technical Advisory Groups (NITAGs) are defined by the World Health Organization as multidisciplinary groups of health experts who are involved in the development of a national immunization policy. The NITAG has the responsibility to provide independent, evidence-informed advice to the policy makers and national programme managers, on policy issues and questions related to immunization and vaccines.This paper aims to describe the NITAG in Israel. The Israeli NITAG was established by the Ministry of Health in1974. The NITAG's full formal name is "the Advisory Committee on Infectious Diseases and Immunizations in Israel". The NITAG is charged with prioritizing choices while granting maximal significance to the national public health considerations. Since 2007, the full minutes of the NITAG's meetings have been publicly available on the committee's website (at the Ministry of Health website, in Hebrew).According to the National Health Insurance Law, all residents of Israel are entitled to receive universal health coverage. The health services basket includes routine childhood immunizations, as well as several adult and post - exposure vaccinations. The main challenge currently facing the NITAG is establishing a process for introducing new vaccines and updating the vaccination schedule through the annual update of the national health basket. In the context of the annual update, vaccines have to "compete" with multiple medications and technologies which are presented to the basket committee for inclusion in the national health basket. Over the years, the Israeli NITAG's recommendations have proved essential for vaccine introduction and scheduling and for communicable diseases control on a national level. The NITAG has established structured and transparent working processes and a decision framework according to WHO standards, which is evidence-based and country-specific to Israel.The recent global COVID-19 pandemic is a major concern for all countries as well as a challenge for NITAGs. Currently, the NITAGs have a key role in advising both on sustainment of the routine immunization programs and on planning of the COVID-19 vaccination campaigns, with ongoing updates and collaboration with the Ministry of Health and health organizations.

Entities:  

Keywords:  Decision-making; Evidence-based policy; Health policy; National Immunization Technical Advisory Group (NITAG); Routine immunization schedule

Year:  2021        PMID: 33499907      PMCID: PMC7835647          DOI: 10.1186/s13584-021-00442-4

Source DB:  PubMed          Journal:  Isr J Health Policy Res        ISSN: 2045-4015


  35 in total

1.  Developing evidence-based immunization recommendations and GRADE.

Authors:  P Duclos; D N Durrheim; A L Reingold; Z A Bhutta; K Vannice; H Rees
Journal:  Vaccine       Date:  2012-03-03       Impact factor: 3.641

2.  National Immunization Technical Advisory Groups (NITAGs): guidance for their establishment and strengthening.

Authors:  Philippe Duclos
Journal:  Vaccine       Date:  2010-04-19       Impact factor: 3.641

Review 3.  The Israel National Immunization Registry.

Authors:  Chen Stein-Zamir; Gary Zentner; Esther Tallen-Gozani; Itamar Grotto
Journal:  Isr Med Assoc J       Date:  2010-05       Impact factor: 0.892

Review 4.  The public health crisis of underimmunisation: a global plan of action.

Authors:  Lawrence O Gostin; James G Hodge; Barry R Bloom; Ayman El-Mohandes; Jonathan Fielding; Peter Hotez; Ann Kurth; Heidi J Larson; Walter A Orenstein; Kenneth Rabin; Scott C Ratzan; Daniel Salmon
Journal:  Lancet Infect Dis       Date:  2019-11-06       Impact factor: 25.071

5.  Israel: Health System Review.

Authors:  Bruce Rosen; Ruth Waitzberg; Sherry Merkur
Journal:  Health Syst Transit       Date:  2015

Review 6.  HPV vaccines: alternative dosage schedules.

Authors:  Margaret Stanley
Journal:  Expert Rev Vaccines       Date:  2019-12-26       Impact factor: 5.217

7.  The rise in travel-associated measles infections-GeoSentinel, 2015-2019.

Authors:  Kristina M Angelo; Michael Libman; Philippe Gautret; Elizabeth Barnett; Martin P Grobusch; Stefan H F Hagmann; Federico Gobbi; Eli Schwartz; Perry J J van Genderen; Hilmer Asgeirsson; Davidson H Hamer
Journal:  J Travel Med       Date:  2019-09-02       Impact factor: 8.490

8.  Immunisation led to a major reduction in paediatric patients hospitalised because of the varicella infection in Israel.

Authors:  Meital Elbaz; Gideon Paret; Avihu Bar Yohai; Ora Halutz; Galia Grisaru-Soen
Journal:  Acta Paediatr       Date:  2016-01-29       Impact factor: 2.299

9.  The Potential for Reducing the Number of Pneumococcal Conjugate Vaccine Doses While Sustaining Herd Immunity in High-Income Countries.

Authors:  Stefan Flasche; Albert Jan Van Hoek; David Goldblatt; W John Edmunds; Katherine L O'Brien; J Anthony G Scott; Elizabeth Miller
Journal:  PLoS Med       Date:  2015-06-09       Impact factor: 11.069

10.  On the implications of desexualizing vaccines against sexually transmitted diseases: health policy challenges in a multicultural society.

Authors:  Baruch Velan; Yaacov Yadgar
Journal:  Isr J Health Policy Res       Date:  2017-07-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.